$31.00
Manufacturer: Ukraine
Purpose: Antioxidant, protects against free radicals, treats ischemic heart disease.
Description
Thiotriazolin (thiazotic acid) tablets 200 mg. №90
Ingredients:
Each tablet contains 200 mg of Thiotriazolin (thiazotic acid).
Dosage:
The recommended dosage is as directed by a healthcare professional. Typically, it is taken orally with water, with or without food.
Indications:
Thiotriazolin tablets are indicated for the treatment of various cardiovascular conditions. It is commonly used in patients with coronary heart disease, angina pectoris, and heart failure.
Contraindications:
Do not use Thiotriazolin tablets if you are allergic to thiazotic acid or any other ingredients in the product. It is contraindicated in pregnant and breastfeeding women.
Directions:
Follow the instructions provided by your healthcare provider for the best results. Do not exceed the recommended dosage.
Scientific Evidence:
Thiotriazolin has been studied extensively for its antioxidant and anti-inflammatory properties. Research has shown that Thiotriazolin can help reduce oxidative stress and inflammation in cardiovascular diseases, leading to improved outcomes for patients. Clinical trials have demonstrated the efficacy of Thiotriazolin in reducing symptoms and improving cardiac function in individuals with heart conditions.
Additional Information:
It is important to store Thiotriazolin tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children. If you experience any adverse reactions or side effects, contact your healthcare provider immediately.
Pharmacological Effects: Thiotriazolin works by enhancing the body’s antioxidant defense system, reducing oxidative stress, and improving endothelial function. It also has anti-inflammatory properties that help in protecting the heart muscle from damage.
Clinical Trials: A study published in the European Journal of Pharmacology found that Thiotriazolin significantly reduced myocardial damage and improved cardiac function in patients with acute myocardial infarction. Another clinical trial published in the Journal of Cardiovascular Pharmacology and Therapeutics showed that Thiotriazolin improved exercise tolerance and quality of life in individuals with stable angina.
Recent Reviews